Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang-Ju Lin

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 22, 2020
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in TaiwanFang-Ju Lin, Kou-Gi Shyu, I-Chang Hsieh, et al.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort studyHiddo J L Heerspink, Avraham Karasik, Marcus Thuresson, et al.
Orphanet Journal of Rare Diseases|June 29, 2016
Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012Hsiang-Yu Lin, Chih-Kuang Chuang, Yu-Hsiu Huang, et al.
Emerging Microbes & Infections|March 16, 2022
Unprecedented outbreak of respiratory syncytial virus in Taiwan associated with ON1 variant emergence between 2010 and 2020Wei-Hsuan Lin, Fang-Tzy Wu, Yi-Yin Chen, et al.
Journal of Clinical Medicine|March 29, 2023
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in TaiwanPatrick Yan-Tyng Liu, Fang-Ju Lin, Chih-Fan Yeh, et al.
Biomedical Journal|August 14, 2023
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation studyYu-Chung Hsiao, Thung-Lip Lee, Fang-Ju Lin, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 22, 2020
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in TaiwanFang-Ju Lin, Kou-Gi Shyu, I-Chang Hsieh, et al.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort studyHiddo J L Heerspink, Avraham Karasik, Marcus Thuresson, et al.
Orphanet Journal of Rare Diseases|June 29, 2016
Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012Hsiang-Yu Lin, Chih-Kuang Chuang, Yu-Hsiu Huang, et al.
Emerging Microbes & Infections|March 16, 2022
Unprecedented outbreak of respiratory syncytial virus in Taiwan associated with ON1 variant emergence between 2010 and 2020Wei-Hsuan Lin, Fang-Tzy Wu, Yi-Yin Chen, et al.
Journal of Clinical Medicine|March 29, 2023
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in TaiwanPatrick Yan-Tyng Liu, Fang-Ju Lin, Chih-Fan Yeh, et al.
Biomedical Journal|August 14, 2023
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation studyYu-Chung Hsiao, Thung-Lip Lee, Fang-Ju Lin, et al.
Pageof 14